Alopecia Treatment Market, By Drug Class (Corticosteroids, 5 AR Inhibitors, Vasodilators, Others), By Disease Type (Alopecia Areata, Androgenic Alopecia, Traction Alopecia, Others), By Route of Administration (Topical, Oral, Injectable Topical application

Alopecia Treatment Market, By Drug Class (Corticosteroids, 5 AR Inhibitors, Vasodilators, Others), By Disease Type (Alopecia Areata, Androgenic Alopecia, Traction Alopecia, Others), By Route of Administration (Topical, Oral, Injectable Topical application), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Alopecia Treatment Market, By Drug Class (Corticosteroids, 5 AR Inhibitors, Vasodilators, Others), By Disease Type (Alopecia Areata, Androgenic Alopecia, Traction Alopecia, Others), By Route of Administration (Topical, Oral, Injectable Topical application), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Alopecia is a medical term that is used to describe the partial or complete loss of hair from areas of the body where hair is normally found. This condition can affect the scalp, eyebrows, eyelashes, beard, or any other part of the body where hair grows. Alopecia can be temporary or permanent, and can occur due to a variety of factors including genetic predisposition, hormonal changes, autoimmune disorders, medical treatments, and certain environmental or psychological factors. There are several types of alopecia, each with distinct characteristics and underlying causes. These include alopecia areata (characterized by patchy hair loss), androgenetic alopecia (commonly known as male-pattern or female-pattern baldness), telogen effluvium (sudden and widespread hair shedding), traction alopecia (caused by repeated pulling or tension on the hair), and others.

Market Dynamics

The key players in operating in the market are focusing on organic growth strategies such as fund raising for alopecia is expected to propel the global alopecia treatment market growth over the forecast period. For instance, in July 2023, Mallia Therapeutics GmbH, a biopharmaceutical company that is developing soluble CD83 (sCD83) for the treatment of hair loss, announced that it had secured its seed financing. The company plans to develop the sCD83 candidate based on preclinical and ex vivo human data, presented at the 20th meeting of the European Hair Research Society (EHRS) held in Sheffield, UK, in June 2023. sCD83 can be applied topically to reach the hair follicle, which is a big advantage as compared to systemic treatment options. Mallia Therapeutics GmbH develops the dual mode of action of sCD83 for the treatment of hormone-induced male or female pattern baldness (= androgenetic alopecia) and autoimmune mediated male or female patchy hair loss (= alopecia areata), the two most prevalent forms of hair loss. Moreover, increasing research and development activities for alopecia treatment is expected to drive global alopecia treatment market growth over the forecast period. For Instance, In November 2022, Equillium, Inc., a clinical-stage biotechnology company, announced that it had initiated a Phase 2 open-label study of EQ101 to assess efficacy and safety in adult subjects with moderate to severe alopecia areata. The study is expected to enroll approximately 30 subjects at multiple clinical sites in Australia.

Key features of the study:

• This report provides an in-depth analysis of the global alopecia treatment market and provides market size (US$ Bn) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global alopecia treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Stemson Therapeutics, OliX Pharmaceuticals, Inc, Pfizer Inc, Aclaris Therapeutics, Inc., Fagron, Follicum AB, Cipla Inc., Arcutis Biotherapeutics, Dr. Reddy’s Laboratories Ltd., Himalaya Wellness Company, Stemson Therapeutics, Cosmo Pharmaceuticals N.V., Equillium, Inc., Eli Lilly and Company, Concert Pharmaceuticals Inc., and Teva Pharmaceutical Industries Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global alopecia treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global alopecia treatment market

Detailed Segmentation:

• Global Alopecia Treatment Market, By Drug Class:
• Corticosteroids
• 5 AR Inhibitors
• Vasodilators
• Others
• Global Alopecia Treatment Market, By Disease Type:
• Alopecia Areata
• Androgenic Alopecia
• Traction Alopecia
• Others
• Global Alopecia Treatment Market, By Route of Administration:
• Topical
• Oral
• Injectable
• Global Alopecia Treatment Market, By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Global Alopecia treatment Market, By Region:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa
• Company Profiles
• Stemson Therapeutics .
• OliX Pharmaceuticals, Inc
• Pfizer Inc
• Aclaris Therapeutics, Inc.
• Fagron
• Follicum AB
• Cipla Inc.,
• Arcutis Biotherapeutics
• Dr. Reddy’s Laboratories Ltd.,
• Himalaya Wellness Company
• Stemson Therapeutics
• Cosmo Pharmaceuticals N.V.
• Equillium, Inc.
• Eli Lilly and Company
• Concert Pharmaceuticals Inc.
• Teva Pharmaceutical Industries Ltd.